These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 35361635)

  • 21. Antimullerian hormone in cases of different reproductive pathologies.
    Barbakadze L; Kristasashvili J
    Georgian Med News; 2014; (232-233):16-21. PubMed ID: 25214265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Relationship Between Serum Anti-Müllerian Hormone and Basal Antral Follicle Count in Infertile Women Under 35 Years: An Assessment of Ovarian Reserve.
    Islam UN; Begum A; Rahman F; Haq MA; Kumar S; Chowdhury K; Sinha S; Haque M; Ahmad R
    Cureus; 2023 Dec; 15(12):e50181. PubMed ID: 38077683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Could hormonal and follicular rearrangements explain timely menopause in unilaterally oophorectomized women?
    Grynberg M; Labrosse J; Bennani Smires B; Sifer C; Peigne M; Sonigo C
    Hum Reprod; 2021 Jun; 36(7):1941-1947. PubMed ID: 34037751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
    Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
    Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships between antral follicle count, blood serum concentration of anti-Müllerian hormone and fertility in mares.
    Traversari J; Aepli H; Knutti B; Lüttgenau J; Bruckmaier RM; Bollwein H
    Schweiz Arch Tierheilkd; 2019 Oct; 161(10):627-638. PubMed ID: 31586925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicentre evaluation of the Elecsys
    Jacobs MH; Reuter LM; Baker VL; Craig LB; Sakkas D; Surrey E; Doody KJ; Jungheim ES; Bayrak AB; Hund M; Verhagen-Kamerbeek WDJ; Pardue D; Buck K; Timm B
    Reprod Biomed Online; 2019 May; 38(5):845-852. PubMed ID: 30930183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
    Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
    Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of age-related changes in anti-Müllerian hormone levels and other ovarian reserve tests between healthy fertile and infertile population.
    Bozkurt B; Erdem M; Mutlu MF; Erdem A; Guler I; Mutlu I; Oktem M
    Hum Fertil (Camb); 2016 Sep; 19(3):192-8. PubMed ID: 27499425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool.
    Anderson RA; Anckaert E; Bosch E; Dewailly D; Dunlop CE; Fehr D; Nardo L; Smitz J; Tremellen K; Denk B; Geistanger A; Hund M
    Fertil Steril; 2015 Apr; 103(4):1074-1080.e4. PubMed ID: 25681853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian response is associated with anogenital distance in patients undergoing controlled ovarian stimulation for IVF.
    Fabregues F; González-Foruria I; Peñarrubia J; Carmona F
    Hum Reprod; 2018 Sep; 33(9):1696-1704. PubMed ID: 30016431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction value of anti-Mullerian hormone (AMH) serum levels and antral follicle count (AFC) in hormonal contraceptive (HC) users and non-HC users undergoing IVF-PGD treatment.
    Bas-Lando M; Rabinowitz R; Farkash R; Algur N; Rubinstein E; Schonberger O; Eldar-Geva T
    Gynecol Endocrinol; 2017 Oct; 33(10):797-800. PubMed ID: 28454495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF.
    Kotanidis L; Nikolettos K; Petousis S; Asimakopoulos B; Chatzimitrou E; Kolios G; Nikolettos N
    J Endocrinol Invest; 2016 Dec; 39(12):1459-1464. PubMed ID: 27465668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women.
    Barbakadze L; Kristesashvili J; Khonelidze N; Tsagareishvili G
    Int J Fertil Steril; 2015; 8(4):393-8. PubMed ID: 25780521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Mullerian Hormone as a Marker of Ovarian Reserve and Function.
    Sinha S; Sharan A; Sinha S
    Cureus; 2022 Sep; 14(9):e29214. PubMed ID: 36128562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian reserve and in vitro fertilization cycles outcome according to women smoking status and stimulation regimen.
    Freour T; Masson D; Dessolle L; Allaoua D; Dejoie T; Mirallie S; Jean M; Barriere P
    Arch Gynecol Obstet; 2012 Apr; 285(4):1177-82. PubMed ID: 22183426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
    Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
    Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between cigarette smoking and ovarian reserve among women seeking fertility care.
    Oladipupo I; Ali T; Hein DW; Pagidas K; Bohler H; Doll MA; Mann ML; Gentry A; Chiang JL; Pierson RC; Torres S; Reece E; Taylor KC
    PLoS One; 2022; 17(12):e0278998. PubMed ID: 36512605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are ovarian reserve tests reliable in predicting ovarian response? Results from a prospective, cross-sectional, single-center analysis.
    Peluso C; Oliveira R; Laporta GZ; Christofolini DM; Fonseca FLA; Laganà AS; Barbosa CP; Bianco B
    Gynecol Endocrinol; 2021 Apr; 37(4):358-366. PubMed ID: 32613875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients.
    Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM
    Hum Reprod; 2021 May; 36(6):1530-1541. PubMed ID: 33822057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.